Asensio has issued numerous reports since last year assailing Network Solutions from all angles and disputing the research conclusions of analysts like Prudential Securities' Paul Merenbloom -- who along with every other analyst except Mr. Asensio, has rated the the company a Buy or Strong Buy.

Luc Hatlestad. Red Herring

Other resources of interest

A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio
 
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
Manuel Asensio Report: Jan. 23, 2004 PolyMedica axes employees.

Manuel Asensio and Asensio.com ("Asensio") report that yesterday The Stewart News reported that PolyMedica Corporation (NASDAQ: PLMD, $26.15) had terminated 25 employees of its Liberty Medical Supply subsidiary. This comes ten days after the announcement of the unexpected immediate resignation of Liberty's President W. Keith Trowbridge. To date PolyMedica has not announced the lay offs to investors. Yesterday's Stewart News article is attached below for your review.

It is Asensio & Company, Inc.’s opinion that PolyMedica's reported criminal conduct has grossly inflated its stated earnings and created liabilities that far exceed its highest-estimated asset value. Exclusive of this evaluation, we believe PolyMedica’s accounting policies have overstated its assets and sales, and understated its expenses. Manuel Asensio and Asensio also have a strong negative opinion about its management. Asensio & Company, Inc. believes PolyMedica’s stock is grossly overvalued. Our reports on PolyMedica are available at www.asensio.com.
 
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
© 2010 Asensioexposes!com offers accurate facts that disproves past criticism of the Manuel Asensio Reports. Web Directory
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.